Reaction

Polyomavirus Viraemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 987 reports · 37 co-occurring drugs

As of the last recalculation, Polyomavirus Viraemia appears in 987 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS OINTMENT 0.1% (PRR 349.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tacrolimus Ointment 0.1%	669	349.5	351.4
Tacrolimus Extended-Release Capsules	669	348.6	350.5
Tacrolimus	689	304.9	306.3
Everolimus Tablets	180	276.6	279.7
Anti-Thymocyte Globulin (Rabbit)	78	221.3	223.5
Mycophenolate Mofetil Hydrochloride	557	196.9	197.7
Mycophenolate Mofetil	555	195.6	196.4
Valganciclovir Hydrochloride Powder,	94	179.5	180.9
Basiliximab	88	173.1	174.4
Mycophenilic Acid	122	141.5	142.4
Valganciclovir	103	128.5	129.2
Valganciclovir Hydrochloride	103	128.5	129.2
Mycophenolic Acid	127	95.9	96.3
Busulfan	66	94.7	95.1
Everolimus	180	91.0	91.3
Sirolimus	54	89.4	89.7
Thiotepa	37	84.8	85.2
Fludarabine Phosphate	106	63.6	63.7
Alemtuzumab	53	61.0	61.2
Ganciclovir Sodium	23	46.9	47.0
Ganciclovir	22	46.3	46.4
Prednisolone	257	40.3	40.3
Prednisolone Oral	257	40.3	40.3
Prednisolone Oral Solution	257	40.3	40.3
Cyclosporine	153	34.1	34.2
Methylprednisolone	174	32.0	32.1
Micafungin Sodium	10	25.1	25.1
Cyclophosphamide Injection, Solution	135	18.5	18.5
Cyclophosphamide	135	18.5	18.5
Cyclophosphamide For Injection	135	18.5	18.5
Melphalan	17	16.0	16.0
Melphalan Hydrochloride	17	14.5	14.5
Eculizumab	34	13.6	13.6
Baricitinib	5	11.0	11.0
Blinatumomab	5	10.2	10.2
Axicabtagene Ciloleucel	3	6.4	6.4
Methoxy Polyethylene Glycol-Epoetin Beta	3	5.7	5.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.